Stock Rating Report for ABT

Ticker: 

Stock Information

Ticker ABT
Company Name Abbott Laboratories
Current Price $55.71
Previous Close $55.71
Industry Drug Manufacturers - Major
Sector HEALTHCARE
Long Stop Loss Members Only
Short Stop Loss Members Only
Expected Move Members Only
Optionable? Yes

StockProphet Ratings

Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.

Sector Risks

Sign up for MarketProphet today to see our 30, 60, and 90 day risk assessment for this stock.


Chart

We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for ABT. However, we only show it to our subscribers.

We update our ratings and stop losses EVERY WEEK.

Don't miss out on what we recommend for Abbott Laboratories next week. Sign up today and start making money!

Demand Fundamentals

Demand Fundamental Value Score Rating
Qtr/Qtr Revenue Growth Members Only
Qtr/Qtr Earnings Growth Members Only
Year/Year Revenue Growth Members Only
Year/Year Earnings Growth Members Only
Multi-Year Revenue Growth Members Only
Multi-Year Earnings Growth Members Only
Relative PE Ranking Members Only
Return on Equity Members Only
Yield Members Only
Institutional Holding Members Only
Stock Price Members Only
Relative Fundamental Ranking Members Only
Total Score Members Only

Demand Technicals

Demand Technical Value Score Rating
Recommended Condition Members Only
Trading Zone Members Only
Average Trading Volume Members Only
Industry Bull/Bear Condition Members Only
Sector Bull/Bear Condition Members Only
Current Signal Start Date Members Only
Total Score Members Only

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. The company offers adult and pediatric pharmaceuticals for rheumatoid and psoriatic arthritis, ankylosing spondylitis, psoriasis, and Crohn's disease- dyslipidemia- HIV infection- prostate cancer, endometriosis and central precocious puberty, and anemia caused by uterine fibroids- respiratory syncytial virus- adult males who have low or no testosterone- secondary hyperparathyroidism- hypothyroidism- and pancreatic exocrine insufficiency, as well as anesthesia products. It also provides diagnostic products, such as immunoassay systems- chemistry systems- assays used for screening and/or diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, physiological, and infectious diseases- instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infections agents- genomic-based tests- hematology systems and reagents- and point-of-care diagnostic systems and tests for blood analysis. In addition, the company offers a line of pediatric and adult nutritional products. Further, it provides coronary, endovascular, vessel closure, and structural heart devices, such as drug-eluting stent systems, coronary metallic stents, balloon dilatation products, coronary guidewires, vessel closure devices, carotid stent systems, percutaneous valve repair systems, and drug eluting bioresorbable vascular products. Additionally, the company provides blood glucose monitoring meters, test strips, data management software, and accessories for people with diabetes- and medical devices for the eye, including cataract surgery, lasik surgery, contact lens, and dry eye products, as well as branded generic pharmaceutical products. Abbott primarily serves retailers, wholesalers, hospitals, and health care facilities. Abbott was founded in 1888 and is headquartered in Abbott Park, Illinois.


Latest News

Tue, 07 Feb 2012 23:02:48 GMTFinal Glance: Medical Devices companies
Tue, 07 Feb 2012 21:20:03 GMT12 Stocks To Hedge Against A Social Security Implosion
Tue, 07 Feb 2012 18:31:21 GMTMake Money in Growing Health Care Stocks the Easy Way
Tue, 07 Feb 2012 18:21:20 GMTMidday Glance: Medical Devices companies
Tue, 07 Feb 2012 17:00:25 GMTThree Big Reasons To Be Bullish On Pharma Stocks
Tue, 07 Feb 2012 15:54:08 GMTLME forced to consider fee hike backlash
Tue, 07 Feb 2012 15:46:51 GMTIPO Preview: ChemoCentryx
Tue, 07 Feb 2012 15:18:59 GMTEarly Glance: Medical Devices companies
Tue, 07 Feb 2012 15:00:00 GMTSiemens Signs First Agreements for Personalized Medicine Diagnostics
Tue, 07 Feb 2012 12:12:13 GMTDealtalk: Nestle in lead to scoop up Pfizer's baby formula unit
Tue, 07 Feb 2012 12:01:22 GMTDEALTALK-Nestle in lead to scoop up Pfizer's baby formula unit
Mon, 06 Feb 2012 22:14:49 GMT5 Low-Beta, Low-Levered Dividend Picks For Retirees
Mon, 06 Feb 2012 20:06:00 GMTDividend Portfolio Playoffs -- Finding The Best Dividend Portfolio
Mon, 06 Feb 2012 19:41:48 GMTIs This Situation Special Enough?
Mon, 06 Feb 2012 18:18:39 GMTMidday Glance: Medical Devices companies
Mon, 06 Feb 2012 15:43:18 GMTWhy You Should Sell These Healthcare Stocks Before They Drop
Mon, 06 Feb 2012 15:32:17 GMTEarly Glance: Medical Devices companies
Mon, 06 Feb 2012 11:28:57 GMTAfter Vodafone stake buy, Piramal to rely on borrowings
Mon, 06 Feb 2012 11:28:57 GMTAfter Vodafone stake buy, Piramal to rely on borrowings
Mon, 06 Feb 2012 11:20:10 GMTUPDATE 1-India's Piramal Healthcare to borrow for future buys
News provided by Yahoo! Finance